← Back to GLP-1 DatabaseActive Ingredient naltrexone hydrochloride / bupropion hydrochloride Drug Class Other Dosage & Administration Oral Approved Indications Weight Loss FDA Approved September 10, 2014
Contrave
naltrexone-bupropion
OtherOralWeight Loss
Manufacturer: Currax PharmaceuticalsFDA Approved: September 10, 2014Starting from $199.00/mo
Overview
Contrave is an oral combination of naltrexone and bupropion approved for chronic weight management, targeting appetite and cravings.
Clinical Data
Weight Loss Efficacy
~5-6% body weight loss in clinical trials
Common Side Effects
nauseaconstipationheadachevomitingdizziness
Community Side-Effect Reports
User-reported data — not medical advice. Consult your healthcare provider.
Provider Pricing
Found
$199.00/mo
✓Consultation included
PlushCare
$225.00/mo
+ consultation fee: $129.00